Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN

Area of Science:

• Immunology
• Nanotechnology
• Drug Delivery Systems

Background:

• Nasally administered vaccines require effective delivery systems to enhance both systemic and mucosal immune responses.
• Liposomes and CpG-ODN are explored as potential components to improve vaccine efficacy.

Purpose of the Study:

• To evaluate liposomes as a drug delivery system and CpG-ODN as an adjuvant for intranasal tetanus toxoid (TT) immunization.
• To determine the impact on systemic and mucosal immune responses in rabbits.

Main Methods:

• Tetanus toxoid (TT) and CpG-ODN were encapsulated in neutral liposomes using the dehydration-rehydration method.
• Liposome characteristics (size, encapsulation efficiency, TT leakage) were analyzed.
• Systemic (serum IgG, antitoxin) and mucosal (sIgA) immune responses were measured post-nasal immunization in rabbits.

Main Results:

• Liposomes showed favorable characteristics: 2.3µm diameter, 54% TT encapsulation, and minimal leakage (7.38% at 3 months).
• Intranasal TT-loaded liposomes significantly increased mucosal sIgA titers.
• CpG-ODN co-administration enhanced serum IgG and antitoxin titers but not mucosal sIgA.

Conclusions:

• Intranasal liposomes encapsulating TT are effective for inducing mucosal immune responses.
• Liposomes offer a promising delivery system for intranasal vaccines, particularly for mucosal immunity.
• CpG-ODN acts as an effective adjuvant for systemic responses but does not enhance mucosal sIgA in this model.